Gain or loss-of-function data in vivo suggest that specific blockade of miR-144 in HSCs mitigated, overexpression of miR-144 in HSCs accelerated the development of experimental liver fibrosis by limiting the SIN3A-p38 axis. The gene discussed is SIN3A; the disease is Hepatic fibrosis.